![]() |
Why LUGPA Embraces Managing Advanced Genitourinary Cancers Neal Shore, MD, FACS |
|
---|---|---|
Medical Director, Certified Physician Investigator |
![]() |
Bladder Cancer Biomarkers: New and Old Michael Cookson, MD |
|
---|---|---|
Professor & Chairman, Department of Urology |
![]() |
AUA Guidelines: Non-muscle Invasive Bladder Cancer Sam Chang, MD |
|
---|---|---|
Professor of Urologic Surgery and Oncology |
![]() |
Intravesical Therapy: When Bacillus Calmette-Guerin Fails Noah Hahn, MD |
|
---|---|---|
Associate Professor of Oncology and Urology |
![]() |
Trinity Bivalacqua, MD, PhD | |
---|---|---|
Director of Urology Oncology |
![]() |
Immunotherapy for Advanced Bladder Cancer: The Next Frontier Arjun Balar, MD |
|
---|---|---|
Assistant Professor, Department of Medicine |
![]() |
Targeted Therapies for Renal Cell Carcinoma Won Kim, MD |
|
---|---|---|
Assistant Professor of Medicine and Urology |
![]() |
Immunotherapy of Renal Cell Carcinoma Hans Hammers, MD, PhD |
|
---|---|---|
Associate Professor, Internal Medicine |
![]() |
Genitourinary Oncology: A Peek Over the Horizon Dan Theodorescu, MD, PhD |
|
---|---|---|
Paul A. Bunn, Jr. Endowed Chair in Cancer Research |
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
Bone Cancer | Regimens | Drugs |
Brain Cancer | Regimens | Drugs |
Breast Cancer | Regimens | Drugs |
Endocrine Cancer | Regimens | Drugs |
Gastrointestinal Cancer | Regimens | Drugs |
Gynecologic Cancer | Regimens | Drugs |
Head and Neck Cancer | Regimens | Drugs |
Hematologic Cancer | Regimens | Drugs |
Lung Cancer | Regimens | Drugs |
Other Cancers | Regimens | |
Prostate Cancer | Regimens | Drugs |
Rare Cancers | Regimens | |
Renal Cell Carcinoma | Regimens | Drugs |
Skin Cancer | Regimens | Drugs |
Urologic Cancers | Regimens | Drugs |
Cancer Therapy Advisor Articles
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- Clinical Applications of Liquid Biopsies in Cancer
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Radical Prostatectomy Compared With Watchful Waiting in Localized Prostate Cancer
- Investigational Antiandrogen Drug Delays Metastasis in CRPC
- Treatment Guidelines in Cancer: Assessing Industry Influence on Recommendations
- American Society of Breast Surgeons Recommends Genetic Testing for All Patients With Breast Cancer
- No Benefit Seen From HSCT in Hypodiploid B-ALL
- Patients With CP-CML Deemed Less Likely to Continue Taking Generic Imatinib
- Opinion: Understanding the FDA's Take on Cannabidiol